These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37200519)

  • 1. Maintaining Warp Speed: Policy Requirements for a Just-in-Time, Capability-Based, Scalable Medical Countermeasure Research and Development Enterprise.
    O'Leary CN; Barnes-Weise J; Hoyt K; Bourdeaux M
    Health Secur; 2023; 21(4):272-279. PubMed ID: 37200519
    [No Abstract]   [Full Text] [Related]  

  • 2. Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.
    Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services
    Fed Regist; 2007 Apr; 72(77):20117-28. PubMed ID: 17520758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. County-Level Planning for Efficient Distribution of Emergency Medical Countermeasures with RealOpt Software.
    de Mesquita PJB; Roush R; Sarkar J
    Health Secur; 2021; 19(5):532-540. PubMed ID: 34609918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incentives for biodefense countermeasure development.
    Matheny J; Mair M; Mulcahy A; Smith BT
    Biosecur Bioterror; 2007 Sep; 5(3):228-38. PubMed ID: 17903091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing Europe for future health threats and crises - the European Health Emergency and Preparedness Authority; improving EU preparedness and response in the area of medical countermeasures.
    Delsaux P
    Euro Surveill; 2022 Nov; 27(47):. PubMed ID: 36695457
    [No Abstract]   [Full Text] [Related]  

  • 6. Project BioShield: what it is, why it is needed, and its accomplishments so far.
    Russell PK
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S68-72. PubMed ID: 17582574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Countermeasure Comics: Visualizing a Public Health Emergency Response.
    Li-Vollmer M
    Am J Public Health; 2018 Jul; 108(7):935-936. PubMed ID: 29874483
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Medical Countermeasures in Small-Scale Emergency Responses.
    Perry IA; Noe RS; Stewart A
    Am J Public Health; 2018 Sep; 108(S3):S196-S201. PubMed ID: 30192656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax countermeasures: current status and future needs.
    Borio LL; Gronvall GK
    Biosecur Bioterror; 2005; 3(2):102-12. PubMed ID: 16000041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: Recent progress in biodefense countermeasure development.
    Mair M
    Biosecur Bioterror; 2006; 4(2):100-6. PubMed ID: 16841397
    [No Abstract]   [Full Text] [Related]  

  • 11. Public Health Emergencies: Unpacking Medical Countermeasures Management for Preparedness and Response Introduction and Contents of the Volume.
    LeBlanc TT; Kosmos C; Avchen RN
    Am J Public Health; 2018 Sep; 108(S3):S173-S174. PubMed ID: 30192667
    [No Abstract]   [Full Text] [Related]  

  • 12. BRIEF REPORT: recent progress in biodefense countermeasure development.
    Mair M
    Biosecur Bioterror; 2005; 3(4):280-5. PubMed ID: 16392161
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioterrorism and disaster preparedness among medical specialties.
    Lane JE; Dimick J; Syrax M; Bhandary M; Rudy BS
    Am J Disaster Med; 2012; 7(1):48-60. PubMed ID: 22649868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparedness. Biodefense network.
    Mills-Senn P
    Hosp Health Netw; 2003 Dec; 77(12):20, 22. PubMed ID: 14712529
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparedness for biological terrorism in the United States: Project BioShield and Beyond.
    Dudley G; McFee RB
    J Am Osteopath Assoc; 2005 Sep; 105(9):417-24. PubMed ID: 16239492
    [No Abstract]   [Full Text] [Related]  

  • 16. BioShield or biogap?
    Alibek K; Bailey C
    Biosecur Bioterror; 2004; 2(2):132-3. PubMed ID: 15225408
    [No Abstract]   [Full Text] [Related]  

  • 17. Notes and comments "High and dry?" The Public Readiness and Emergency Preparedness Act and liability protection for pharmaceutical manufacturers.
    Copper BK
    J Health Law; 2007; 40(1):65-105. PubMed ID: 17549932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS.
    Homer MJ; Raulli R; DiCarlo-Cohen AL; Esker J; Hrdina C; Maidment BW; Moyer B; Rios C; Macchiarini F; Prasanna PG; Wathen L
    Radiat Prot Dosimetry; 2016 Sep; 171(1):85-98. PubMed ID: 27590469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the gaps between biodefense researchers, public health, and clinical practice in a rural community.
    Van Fleet-Green JM; Chen FM; House P
    J Rural Health; 2008; 24(3):326-9. PubMed ID: 18643813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research and development policy on bioterrorism medical countermeasures in the United States].
    Saito T; Takeuchi T
    Kansenshogaku Zasshi; 2009 Jan; 83(1):1-6. PubMed ID: 19227217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.